Evaluating the efficacy of rimegepant as a preventive treatment for chronic and episodic migraine: a three-month longitudinal retrospective cohort study - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessing the Effectiveness of Rimegepant for Preventing Chronic and Episodic Migraine: A Three-Month Retrospective Cohort Analysis

  • By

  • Hamza Khan

  • Muhammad Saqib Khan

  • Sheraz Khan

  • Fang Liu

  • Quan Feng

  • Irfan Ahmad

  • Ge Tan

  • June 4, 2026

Share

Original Source(s)

Evaluating the efficacy of rimegepant as a preventive treatment for chronic and episodic migraine: a three-month longitudinal retrospective cohort study

  • by Hamza Khan, Muhammad Saqib Khan, Sheraz Khan, Fang Liu, Quan Feng, Irfan Ahmad, Ge Tan

  • June 4, 2026

Related Content

The association between social risk profile and self-reported severe headache or migraine with all-cause mortality risk: A machine learning-based prediction model and interpretability analysis

Clinical Insights: A Reversible Autonomic-Endothelial Migraine Phenomenon Demonstrated Through a Case Study

Caffeine use disorder and analgesic dependence in medication-overuse headache: insights into an underrecognized relationship